Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe injection site for Mounjaro does not determine how much weight you lose. Tirzepatide's effectiveness comes from the medicine itself, absorbed into subcutaneous fat and then into the bloodstream — the abdomen, thigh, and upper arm all deliver it reliably. What the site does affect is comfort, absorption consistency, and your long-term willingness to keep injecting. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Search for this topic and you will find confident claims that injecting into the abdomen produces dramatically better weight loss than the thigh, or that rotating sites somehow dilutes the medicine's effect. Neither is accurate. The NHS patient guidance on tirzepatide lists the abdomen, outer thigh, and upper arm as equally valid sites, and the licensed prescribing information does not rank them by effectiveness for weight loss.
What pharmacokinetic research does show is that subcutaneous absorption from the abdomen tends to be slightly faster and marginally more consistent than from the thigh or arm, but this difference in absorption speed does not translate into meaningfully different clinical outcomes. SURMOUNT-1, which involved 2,539 adults and produced average weight loss of around 20–21% at the 15 mg dose, did not instruct participants to use a single preferred site.
The practical takeaway: choose the site that is easiest for you to reach and inject correctly. A well-executed injection into your thigh is far more effective than a hurried, incorrectly-angled jab into your abdomen. Comfort and consistency drive results more than geography.
Rotating injection sites is not optional housekeeping. Use the same small patch of skin week after week and you risk lipohypertrophy, an accumulation of fibrous scar-like tissue under the skin. That tissue absorbs medicine erratically: some weeks too slowly, some weeks too fast, making it harder to predict how your dose behaves.
The practical approach is to divide each licensed area into a grid of smaller zones and move around that grid. On the abdomen, avoid the two-inch ring around the navel; on the thigh, use the outer face of the mid-thigh; on the upper arm, use the outer or back surface. Keep a rough mental note of where you injected last time. Many people find a simple weekly rota (abdomen one week, left thigh the next, right thigh the next) easy to maintain. If you are approaching a planned holiday or a bank holiday week, work out your rotation in advance so a shifted injection day does not land on the same site twice in quick succession.
If you notice any persistent lump, tenderness, or skin change at an injection site, contact your prescribing team before your next dose.
Site matters less than technique. The Mounjaro KwikPen delivers a fixed dose; your job is to make sure it reaches the subcutaneous fat layer cleanly.
A few points that apply wherever you inject: take the pen out of the fridge and let it sit at room temperature for around 30 minutes before injecting, a cold pen is more likely to sting. Clean the skin with an alcohol swab and let it dry fully before pressing the pen down. If you have very little subcutaneous fat at the chosen site, pinch the skin gently to create a fold; this reduces the risk of an intramuscular injection, which is both more painful and slower to absorb. Hold the pen flat against the skin at a 90-degree angle, press and hold for the full count indicated in the Patient Information Leaflet, and then remove it slowly.
Using a fresh needle for every injection is not just a hygiene rule: a used needle's tip deforms microscopically, making the injection rougher and raising infection risk. The Mounjaro SmPC on the eMC and the included leaflet carry the full instructions, read them once carefully and refer back whenever something feels different. For questions about technique that aren't covered there, our aftercare team is available seven days a week.
For most people starting Mounjaro, the abdomen is the easiest site: it's easy to see, easy to reach, and the skin is generally plentiful enough to inject without pinching. The thigh is a good alternative for anyone who finds the abdomen uncomfortable, and if you are still weighing up your options, our guide covering where the best place to inject Mounjaro for weight loss really is walks through each area in plain language to help you decide.
Over a long course of treatment, using all three sites in rotation preserves tissue health across all of them. You can find a fuller breakdown of site-by-site considerations, including practical advice on choosing the best place to inject Mounjaro for weight loss based on your body and lifestyle, on the injection-site guidance page, including what to do if one area becomes consistently uncomfortable.
The broader context matters too. Injection site is one small variable in a treatment that includes titrated dosing, dietary changes, and ongoing clinical review. If you are thinking about starting tirzepatide or are considering the cost involved, the pricing context page sets out how UK private costs have changed since Eli Lilly's 2025 list-price revision, worth reading before you compare providers. When you are ready to talk through your suitability, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.